We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
cancel
Tanezumab
Tanezumab is a monoclonal antibody that targets nerve growth factor, potentially affecting how the body processes pain. Tanezumab has been examined for its effect on pain.